ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #10,483Hybrid

Asia-Pacific Journal of Clinical Oncology

Acronym:apjco
•
Abbreviation (ISO):ASIA-PAC J CLIN ONCO
•
Identifier (ISSN):1743-7555(Print)/1743-7563(Online)
•
Publisher:Wiley-Blackwell Publishing Ltd
Clarivate IF (2026)
2.1↑ +0.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Asia-Pacific Journal of Clinical Oncology

WoS Q3
01341.4920181.5420192.0120202.620211.9320221.920231.420241.620252.12026
Annual Impact Factor Metric
Current (2026):2.1
Scopus SJR & RankScopus Q2
0.565
#10,483

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
49

49 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
118articles/year
36.4% Gold OA•87.07% Original Research

Aims & Scope

Asia–Pacific Journal of Clinical Oncology is a multidisciplinary journal of oncology that aims to be a forum for facilitating collaboration and exchanging information on what is happening in different countries of the Asia–Pacific region in relation to cancer treatment and care. The Journal is ideally positioned to receive publications that deal with diversity in cancer behavior, management and outcome related to ethnic, cultural, economic and other differences between populations. In addition to original articles, the Journal publishes reviews, editorials, letters to the Editor and short communications. Case reports are generally not considered for publication, only exceptional papers in which Editors find extraordinary oncological value may be considered for review. The Journal encourages clinical studies, particularly prospectively designed clinical trials.

Topics Covered (Recognized by AI)
Medicine65.7%Biology59.6%Internal medicine58.8%Genetics52.8%Cancer44.3%Pathology38.7%Surgery34.7%Computer science32.6%Oncology31.8%Psychology20.1%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q3
Rank236/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q4
Rank275/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.1
Articles / Year106
Total Citations11
2025
IF1.6
Articles / Year152
Total Citations118
2024
IF1.4
Articles / Year103
Total Citations227
2023
IF1.9
Articles / Year132
Total Citations499
2022
IF1.926
Articles / Year204
Total Citations1,046

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,483Scopus Q2SCImago Profile
Scopus Coverage:2006-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
0.565

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
1.91

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,963 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations676
3-Year Documents374
Citable Documents355

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate41.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q2
OncologyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Asia-Pacific Journal of Clinical Oncology (acronym: apjco, abbr: ASIA-PAC J CLIN ONCO, ISSN: 1743-7555) is a peer-reviewed international scholarly journal in the field of Medicine, published by Wiley-Blackwell Publishing Ltd in Australia since 2005. The periodical holds a Journal Impact Factor (JIF) of 2.10, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.565 (Q2), an H-index of 49.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 118 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,963 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Wiley-Blackwell Publishing Ltd
Publication Language
English
Frequency
Quarterly
Founding Year
2005
Indexing & Databases
SCIEScopusPubMed
Editorial Address
WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: dfc7532c-7ac2-496e-affe-97c05e5ac6aa
Database Updated: 2026-10-01